Cerebrocardiac thrombotic disease such as acute myocardial infarction and acute ischemic stroke cause signifieant morbidity and mortality.Present therapies for these diseases besides anticoagulation and fibrinolysis mainly aim toward limiting platelet adhesion and aggregation processes.However,their incomplete effectiveness suggests that other mechanisms may be important.